Clinical Trial Update: Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ovicidal efficacy and safety of abametapir 0.74% lotion for treating head lice infestation has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head Lice Infestation

Drugs mentioned

• Abametapir Lotion 0.74% (abametapir)

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Head Lice Infestation | Phase 2 | Status: COMPLETED | Results posted: 2021-05-11